Background: The multiple wavelets and functional re-entry hypotheses are mechanistic theories to explain atrial fibrillation (AF). If valid, a chamber's ability to support AF should depend upon the left atrial size, conduction velocity (CV), and refractoriness. Measurement of these parameters could provide a new therapeutic target for AF. We investigated the relationship between left atrial effective conducting size (LA ECS ), a function of area, CV and refractoriness, and AF vulnerability in patients undergoing AF ablation.
| INTRODUCTION
The multiple wavelet hypothesis, initially proposed by Moe et al 1 in the 1950s, is an established mechanistic theory to explain the maintenance of atrial fibrillation (AF). According to this theory, sustained fibrillatory activity is the result of multiple random independent wavefronts propagating across an altered electrical substrate which maintain fibrillation after the initial trigger is extinguished. Support for the multiple wavelet hypothesis was originally demonstrated in a canine model of cholinergic AF, 2 but more recently both electrocardiographic imaging during AF in patients with paroxysmal, persistent and long-standing persistent AF, 3 and epicardial mapping in patients with persistent AF undergoing open heart surgery 4 have further supported this mechanism in human AF.
Another important mechanistic theory of AF, that of "functional re-entry," was proposed by Allessie et al 5 in an ex vivo study of rabbit atria. In this study, rotating re-entry occurred in the absence of an anatomical obstacle. Subsequent studies further demonstrated functional, anatomic, and micro re-entry to be driving mechanisms in animal models of AF. 6, 7 In the modern era two new technologies (intracardiac phase mapping 8 and electrocardiographic imaging 9 ) have also been used to demonstrate, albeit controversially, the occurrence of rotors in human AF, described previously as drivers of function re-entry. 10 Since directly mapping activation in AF is challenging, our ability to deliver therapies based on such mechanisms is currently limited.
Nevertheless, a key concept of these hypotheses is that a critical mass of tissue is required to facilitate the perpetuation of AF. 11 Whether chamber size determines the capacity of the chamber to sustain multiple re-entrant wavelets will depend on the electrical properties (conduction velocity [CV] and refractoriness) of that chamber. 12 A technique to quantify the electrical substrate size of an atrium, based on a limited set of measurements collectible within a clinically applicable timescale, would allow interventional AF treatments to be individualized. We therefore propose a metric termed "Effective Conducting Size" (units, cm) which is a function of total atrial area, CV, and a single-site measurement of refractoriness. We hypothesize that the ability of a chamber to support AF is related to Effective Conducting Size, independent of the use of antiarrhythmic medication. 
| Left atrial mapping and pacing protocol
Before ablation, all patients underwent left atrial activation and voltage mapping using the Carto electro-anatomic mapping system (Biosense Webster, Diamond Bar, CA) during coronary sinus pacing at a cycle length of 600 milliseconds. For patients who presented in AF, direct current cardioversion was performed. Wide-area encirclement of the pulmonary veins was performed in power-controlled mode using a contact force-sensing ablation catheter. Entrance and exit block were demonstrated to confirm pulmonary vein isolation and additional ablation performed in the case of reconnection. Following successful pulmonary vein isolation, the ablation catheter was positioned in the center of the posterior left atrial wall. Once adequate contact force (>3 g) and catheter stability were achieved, a pacing protocol was applied consisting of an 8-beat drive train at a basic cycle length (BCL) of 600 milliseconds and an extra stimulus with coupling intervals reducing from 450 milliseconds in 10 millisecond steps. The atrial effective refractory period (ERP) was defined as the longest extra stimulus coupling interval failing to capture the atrium.
| AF vulnerability
Following ERP measurements, an AF induction protocol was performed by pacing from the ablation catheter at the left atrial WILLIAMS ET AL.
| 1417 posterior wall. The protocol consisted of sensed doubles (S1 = 600 milliseconds; S2 = 400 milliseconds, decreasing in 10 milliseconds steps to atrial ERP), sensed triples S1 = 600 milliseconds; S2 =ERP + 50 milliseconds, S3 =ERP + 50 milliseconds, decreasing in 10 millisecond steps to atrial ERP) and incremental pacing, decreasing in 10 millisecond intervals from 450 milliseconds to loss of 1:1 atrial capture. 13 Each step in the induction protocol was carried out once before moving onto the subsequent step. If AF was not induced by this protocol the entire protocol was repeated for a second time.
Sustained AF was defined as AF continuing for greater than 30 seconds. If AF resolved to an organized tachycardia, overdrive pacing was used to terminate the tachycardia. Sustained AF was terminated by electrical cardioversion if required. (G Na = 16 mS/cm 2 , G K = 0.423 mS/cm 2, and G Si = 0.085 mS/cm 2 ). 14, 15 AF is sustained in this model by multiple wavelets undergoing functional re-entry and wave break. 15 The 3 | RESULTS
| Calculation of LA ECS

| Statistical analysis
| Demographics and procedural details
Thirty-nine patients (21 paroxysmal AF, 18 persistent AF) undergoing first-time AF ablation were studied (Table 1) . Mean AF history was 28 ± 37.4 months. Thirty patients were receiving rate-controlling agents periprocedurally (β-blockers n = 26; verapamil n = 3, digoxin n = 3) and 16 were taking antiarrhythmic medications (amiodarone n = 4; flecainide n = 10, others n = 2). Sustained AF was inducible in 14 (36%) patients overall (7 paroxysmal AF, 7 persistent AF).
| Measured parameters and calculated parameters
Mean left atrial body area was 86. 
| Simulated data
2D simulations
Baseline parameter sets were chosen to model multiple wavelet re-entry with the ERP tuned to match the mean value for the inducible persistent AF patients. AF was sustained for this set-up ( Figure 6A ) with a calculated LA ECS = 6.18 cm (filled hexagon; Figure 6D In 76% of the simulations, AF sustained after pulmonary vein isolation ( Figure 8A) . Applying a box isolation lesion set further reduced LA ECS and terminated AF in 67% of simulation set-ups using the inferior line that resulted in the lowest LA ECS . Figure 8B shows an example in which AF was inducible with the smallest area of isolated tissue owing to a resultant atrial area of 121 cm 2 and corresponding LA ECS of 5.82 cm. Figure 8C shows the same anatomy, ERP and CV properties as Figure 8B . In this case, increasing the area of the isolated posterior box resulted in a LA ECS of 3.94 cm, and termination of AF. In contrast, Figure 8D demonstrates a case in which AF is still inducible following the largest box isolation lesion set with an ERP of 230 milliseconds and LA ECS remaining above 4 cm (LA ECS = 4.18 cm).
By additionally increasing ERP to 250 milliseconds, through modeling the effects of sotalol, LA ECS is decreased less than 4 cm (LA ECS = 3.84 cm) and AF terminates ( Figure 8E ).
| DISCUSSION
In this study, we sought to design and test a clinically applicable These findings support a future role for LA ECS in guiding interventional, pharmacological or combined therapies for persistent AF.
| Atrial size, electrical remodeling, and AF vulnerability
Left atrial dilatation is a well-described risk factor for the development of AF and is associated with disease severity and outcome post ablation. 18 These data demonstrate that left atrial body area is significantly associated with both AF severity (persistent vs paroxysmal AF) and AF vulnerability in persistent AF cases. The mechanisms by which atrial dilatation may increase AF vulnerability are incompletely understood. According to the multiple wavelet hypothesis, an increased atrial area would allow more re-entrant circuits to exist 1, 19 and thus increase susceptibility to AF. However, alterations in electrical properties could also be associated with atrial dilatation and contribute to the maintenance of AF.
Prior studies assessing the relationship between electrical acute dilatation in isolated rabbit atria 22 and an association between reduced CV, atrial dilation, and arrhythmias has also been shown in human studies. 23 In the present study, we found no significant relationship between left atrial size and ERP or total activation time in patients with either paroxysmal and persistent AF, although a nonsignificant trend toward shorter ERP and longer total activation time were noted in persistent patients with inducible vs noninducible AF. Therefore, there is a need to consider both atrial size and electrical conduction together (for example using LA ECS ) in individual patients to predict response to treatments for arrhythmias.
| The concept of Re-entry, wavelength, and atrial substrate size
The concept of "atrial substrate size" was originally communicated by Moe in terms of a dimensionless quantity termed the fibrillation number. 19 In a study by Hwang et al, 24 predicting arrhythmia vulnerability in a canine study. 26 Given the interaction between atrial size, refractoriness, CV, and AF vulnerability, we incorporated these parameters into a new metric termed LA ECS . This metric differs from the fibrillation number previously described 19, 24 by using atrial surface area rather than a characteristic length constant such as atrial diameter which we believe is likely to better capture the complex geometrical remodeling present in AF patients. 27 We extended the above findings to a population of AF patients by demonstrating that wavelength is significantly shorter and LA ECS significantly greater in persistent AF patients with inducible vs noninducible AF ( Figure 4F ). LA ECS also notably identified a population of patients with persistent AF who were not AF-inducible after PVI and who, from an electrophysiological standpoint, appear to behave more like substrate modification is likely to be required. In these patients, initial trigger-dependent AF may have evolved to multiple wavelet/re-entry based AF due to progressive structural and electrical remodeling. 30 In recent years, additional catheter ablation strategies have been suggested in persistent AF patients [31] [32] [33] , however, the optimal treatment approach remains unclear. 34 According to the present data targeted strategies to reduce LA ECS (Figures 6D and 8) may improve the success of rhythm control strategies. In contemporary practice, a reduction in LA ECS could be achieved by positioning the PV wide-area encirclement lines more toward the center of the chamber, by isolating F I G U R E 8 Left atrial effective size-based arrhythmia therapy insights from patient-specific simulations. A, AF is inducible post-pulmonary vein isolation for the largest anatomy (area 140 cm 2 ) with an ERP of 270 milliseconds (LA ECS = 6.73 cm). Isopotential plots are shown for time points at 250 milliseconds intervals. B, AF is inducible after applying the smallest box isolation ablation to the largest anatomy (remaining left atrial body area, 121 cm 2 ) with an ERP of 270 milliseconds (LA ECS = 5.82 cm). C, AF is noninducible after applying the largest box isolation ablation to the largest anatomy (remaining left atrial body area, 82 cm 2 ) with an ERP of 270 milliseconds (LA ECS = 3.94 cm). Together "B" and "C" show that reducing the remaining left atrial body area is a viable therapeutic strategy to reduce LA ECS and AF inducibility. D, AF is inducible after applying the largest box isolation ablation to the medium anatomy (remaining left atrial body area, 74 cm 2 ) with an ERP of 230 milliseconds (LA ECS = 4.18 cm). E, Modifying the ERP to 250 milliseconds for the case in "D" results in non-inducibility (LA ECS = 3.84 cm). Together "D" and "E" show that in certain cases combined the use of ablation and antiarrhythmic drugs may be needed to achieve the necessary reduction in LAECS and prevent AF inducibility. Dotted red lines indicate ablation lesion trajectories. "A"-"C" (largest anatomy) are shown in posteroanterior orientation. D-E, (medium anatomy) are shown in anteroposterior orientation with cranial tilt. AF, atrial fibrillation; ERP, effective refractory period; LA ECS , LA effective conducting size the LA posterior wall 35 or by the selective use of antiarrhythmic drugs to prolong atrial refractoriness. Our modeling data highlights how in certain cases even a large posterior box isolation set does not reduce the LA ECS sufficiently to terminate AF and this is only achieved through an additional increase in ERP. As such, knowledge of LA ECS could be used to guide ablation during the initial ablation procedure or to guide the selection of additional ablation vs. antiarrhythmic drugs for the management of recurrent arrhythmia after initial ablation. Such management strategies require investigation in prospective randomized trials.
| LIMITATIONS
This was a prospective simulation/clinical study to evaluate a new clinically applicable concept. Since there were a low number of recurrence events in the cohort, it was not possible to formally test the predictive power of LA ECS in a statistical model including other clinical parameters associated with AF vulnerability and recurrence. ERP was measured at a single site in the left atrium which may not be fully reflective of the heterogeneity in refractoriness seen in patients with persistent AF. Some patients were maintained on antiarrhythmic drugs periprocedurally. While the effects of these in terms of CV and refractoriness will be accounted for in the LA ECS concept, it is not possible to predict how discontinuation of medications post procedure may affect the vulnerability to AF in a particular patient from these data.
Therefore, LA ECS measured in the study may not reflect the true LA ECS once antiarrhythmic drugs are either discontinued or resumed post procedure. This study focused on multiple wavelet mechanisms of AF only. It is possible that this hypothesis may hold for other forms of re-entry in including micro-entrant circuits and rotors however this was not explored in the modeling work carried out here. Similarly, we did not examine the potential roles of the right atrium in arrhythmogenesis in these patients.
| CONCLUSION
LA ECS was significantly associated with the ability to induce AF in patients post first-time ablation for persistent, but not paroxysmal AF. These data support the mechanistic hypotheses of re-entry in the population of persistent AF patients studied. The LA ECS metric may be useful for predicting AF vulnerability and guiding arrhythmia management in such patients.
